Operations

Avara Pharmaceutical Services acquires Consumer Healthcare facility from GSK in Aiken, South Carolina

September 22, 2017

NORWALK, Conn., Sept. 21, 2017 /PRNewswire/ — Avara Pharmaceutical Services has signed an agreement with GSK to acquire a GSK consumer healthcare manufacturing facility in Aiken, South Carolina. “This acquisition is an important component of our strategic plan and expands our services by adding additional solid dose capability in the United States, which is in […]

Poxel Reports Results for the First Half 2017 and Provides Corporate Update

September 22, 2017

LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes, announced today its results for the first half of 2017 ended June 30, 2017, and provided a corporate update. As of June 30, 2017, cash and cash equivalents were […]

Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer

September 22, 2017

IRVING, Texas, September 19, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the appointment of W. Michael Korn, M.D., as its Chief Medical Officer. In this role, Dr. Korn will guide Caris’ research efforts and clinical strategies for the company’s innovative precision […]

Realm Therapeutics Announces $26 Million PIPE Financing

September 22, 2017

MALVERN, PA–(Marketwired – Sep 21, 2017) – Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology, is pleased to announce today that it has successfully secured funding commitments to raise gross proceeds of $26 million through a private placement in the United States and the United Kingdom […]

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 22, 2017

SOUTH PLAINFIELD, N.J., Sept. 21, 2017 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 18, 2017 it approved non-statutory stock options to purchase an aggregate of 32,500 shares of its common stock to thirteen new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of […]

Bayer Appoints Dr. Sharon James Head of Global Innovation & Development for Consumer Health

September 22, 2017

BASEL, Switzerland, Sept. 22, 2017 /PRNewswire/ — Bayer today announced the appointment of Dr. Sharon James as Head of the Global Innovation & Development (I&D) organization of the Consumer Health Division, effective October 2, 2017. Dr. James succeeds Dr. John O’Mullane, who will retire from the company on December 31, 2017 after 30 years in […]

Juno Therapeutics Opens New Headquarters and Research Center

September 22, 2017

SEATTLE–(BUSINESS WIRE)–Juno Therapeutics, Inc. (NASDAQ: JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today unveiled its new headquarters and research facility, located in the heart of South Lake Union in Seattle.   The new headquarters brings together Juno’s Seattle employees – previously spread among three locations – enabling the company’s […]

Juno Therapeutics Prices $250 Million Follow-on Offering

September 22, 2017

SEATTLE–(BUSINESS WIRE)–Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced the pricing of its follow-on public offering of 6,100,000 shares of its common stock at a price to the public of $41.00 per share. In addition, Juno has granted the underwriters a 30-day option to purchase […]

eClinicalHealth Clinpal™ Team Continues Expansion Using Technology Platform to Support Virtual Trial Solutions

September 22, 2017

STIRLING, Scotland–(BUSINESS WIRE)–eClinicalHealth Limited, a cloud-based eClinical technology company, announces continued expansion in patient-centric trial models and increased therapeutic areas.   #Clinpal expands #DirectToPatient focus for #RemoteResearch in #ClinicalTrials w/ #PatientDashboards and #BYOD. Tweet this With nearly six years of delivery experience, Clinpal has recently launched new studies to support the important needs of biopharmaceutical […]

Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

September 22, 2017

Basel, September 22, 2017 – Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current patients with chronic myeloid leukemia (CML), gastrointestinal tumors (GIST) and other rare cancers. The two organizations have been long-time collaborators in providing access to care for patients in […]

Arvinas Appoints Dr. John Houston as President and Chief Executive Officer

September 21, 2017

NEW HAVEN, Conn., September 20, 2017 – Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, today announced the appointment of John Houston, Ph.D., as president and chief executive officer. Dr. Houston will also join the board of directors of Arvinas Holding Company, LLC, and all of its […]

Susman Godfrey Client Wellstat Therapeutics Awarded More Than $70 Million by Delaware Court

September 21, 2017

HOUSTON and NEW YORK (September 20, 2017) — Susman Godfrey client, Wellstat Therapeutics, has been awarded an estimated $70 million against BTG International, Inc. in a pharmaceutical contract dispute in the Delaware Court of Chancery. Vice Chancellor J. Travis Laster issued a Memorandum Opinion on Tuesday, awarding Wellstat $55.8 million in damages plus prejudgment interest […]

CBRE/NE Announces Corbus Pharmaceuticals Triples Its Footprint in Norwood

September 21, 2017

BOSTON–(BUSINESS WIRE)–CBRE/New England today announced that Corbus Pharmaceuticals has strengthened its relationship with Cornerstone Corporation, entering into an agreement with the management agent for River Ridge Office Park, to expand and relocate within River Ridge Office Park in Norwood, Mass. The Phase 3 clinical-stage pharmaceutical company will move into a newly renovated 32,733 SF facility […]

Pfizer Goes to Court to Allow Competition for Biologics and Expand Options for Patients Lawsuit Claims Johnson & Johnson Engaged in Unlawful Conduct to Stifle Competition From Inflectra

September 21, 2017

NEW YORK–(BUSINESS WIRE)–To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer (NYSE:PFE) today filed suit in the U.S. District Court for the Eastern District of Pennsylvania against Johnson & Johnson (J&J).   “Forward-Looking Information and Factors That May Affect Future Results” Tweet this The suit alleges that J&J’s exclusionary contracts […]

Sucampo Pharmaceuticals Appoints Alex Driggs as General Counsel

September 21, 2017

ROCKVILLE, Md., Sept. 20, 2017 (GLOBE NEWSWIRE) — Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced the appointment of Alex Driggs to General Counsel and Corporate Secretary. Mr. Driggs joined Sucampo in May 2015 as Associate General Counsel, was appointed its Deputy General Counsel in September 2015, and has most recently served […]

Envigo appoints Chief Commercial Officer and President of EMEA Operations

September 21, 2017

Princeton, NJ, September 21, 2017: Envigo announced today that it has made two new appointments to its Executive Committee. The appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer […]

3D Communications Expands Value Communications for Market Access Services with the Addition of Liz Scherer

September 21, 2017

WASHINGTON, Sept. 20, 2017 /PRNewswire/ — 3D Communications LLC today announced the expansion of its global Value Communications for Market Access services adding Liz Scherer, a seasoned communications executive. Liz brings to 3D experience across multiple aspects of the pharma development process – from R&D and Regulatory to Marketing and Commercialization.   “Bringing Liz onto […]

UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team

September 21, 2017

SAN FRANCISCO, Sept. 21, 2017 — UNITY Biotechnology, Inc. (“UNITY”), a privately held biotechnology company creating therapeutics that prevent, halt, or reverse numerous diseases of aging, today announced recent additions to its executive team. Joining as chief financial officer is Bob Goeltz. Bob was most recently chief financial officer of CytomX Therapeutics [NASDAQ: CTMX], where […]

Lipocine Announces Motions Decision by USPTO in Interference Against Clarus

September 21, 2017

SALT LAKE CITY , Sept. 21, 2017 (GLOBE NEWSWIRE) — Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark Office (“USPTO”) issued a Motions Decision based on each party’s motions in the interference case, Patent Interference No. 106,045, between Clarus […]

Juno Therapeutics Launches Follow-on Offering

September 21, 2017

SEATTLE–(BUSINESS WIRE)–Juno Therapeutics, Inc. (NASDAQ:JUNO), a biopharmaceutical company developing innovative cellular immunotherapies for the treatment of cancer, today announced the launch of a proposed follow-on public offering of $225 million of shares of its common stock. In addition, Juno expects to grant the underwriters a 30-day option to purchase up to an additional $33.75 million […]

Acceleron Announces Pricing of Public Offering of Common Stock

September 21, 2017

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (NASDAQ:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics intended to treat serious and rare hematologic, neuromuscular, and pulmonary diseases, today announced that it has priced an underwritten public offering of 5,405,406 shares of common stock at a price to the public of $37.00 per share […]

Landos Biopharma Raises $10 Million in Series A Financing

September 21, 2017

BOSTON & BLACKSBURG, Va.–(BUSINESS WIRE)–Landos Biopharma, Inc., an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases, announced today it has raised $10 million in a Series A financing led by life sciences investment management firm Perceptive Advisors, LLC, which will serve as its exclusive investor for the Series A round.   @LandosBio […]

iMedicare and Mirixa Announce Partnership to Optimize Medication Adherence Services

September 21, 2017

NEW YORK–(BUSINESS WIRE)–iMedicare, the leading decision automation platform for pharmacies, and Mirixa Corporation, a leading healthcare technology and services company offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, today announced their partnership to integrate patient counseling opportunities into the workflow of thousands of community pharmacies.   iMedicare and Mirixa announce partnership […]

Sir Andrew Witty, Former CEO of GSK, Joins Synthego Advisory Board

September 21, 2017

Redwood City, California – Sept. 20, 2017 – Synthego, a leading provider of genome engineering solutions, announces the appointment of Sir Andrew Witty, former CEO of GlaxoSmithKline (GSK) and Director at UnitedHealth Group, to the Synthego advisory board. “Synthego’s vision for automating biological research will revolutionize the industry by accelerating application development and enabling machine […]

Study Shows Gender Gap in Life Sciences Sector Perpetuated by Companies’ Culture, Processes and Talent Management

September 21, 2017

September 21, 2017 (CAMBRIDGE, MA) – The Massachusetts Biotechnology Council (MassBio) and executive recruiting company Liftstream today released a new report, “Opening the Path to a Diverse Future,” a study examining the cause behind the lack of gender diversity within the Massachusetts life sciences sector. This report, the most extensive of its kind, explores the […]

Industry Survey Reveals Clinical Data Management Delays Are Slowing Trial Completion

September 21, 2017

BOSTON and PLEASANTON, CA — Sept. 21, 2017 — One of the largest, most in-depth surveys of clinical data management professionals shows that the time it takes companies to design and release clinical study databases is having a negative impact on conducting and completing trials.   According to the 2017 eClinical Landscape Study from Tufts […]

Roivant Sciences Launches Datavant to Improve Clinical Trials with Artificial Intelligence

September 20, 2017

SAN FRANCISCO and BASEL, Switzerland, Sept. 20, 2017 /PRNewswire/ — Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients and their families, today announced the launch of Datavant, a new company focused on employing artificial intelligence to improve the clinical trial process. […]

HTG Announces Issuance of Two Method Patents Related to its Technology

September 20, 2017

TUCSON, Ariz., Sept. 20, 2017 (GLOBE NEWSWIRE) — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the United States Patent and Trademark Office has issued two U.S. Patents covering HTG’s technology and applications of its technology. The first patent, U.S. Patent 9,758,829 entitled Molecular Malignancy […]

FEEDBACK